Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-12 19:51:01 UTC |
---|
Update Date | 2022-03-07 02:49:18 UTC |
---|
HMDB ID | HMDB0003375 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | (+)-Limonene |
---|
Description | (+)-Limonene, also known as d-limonene, is a naturally occurring monoterpene which is the major component in orange oil. Currently, (+)-limonene is widely used as a flavour and fragrance and is listed to be generally recognized as safe in food by the Food and Drug Administration (21 CFR 182.60 in the Code of Federal Regulations, U.S.A.). Recently, however, (+)-limonene has been shown to cause a male rat-specific kidney toxicity referred to as hyaline droplet nephropathy. Furthermore, chronic exposure to (+)-limonene causes a significant incidence of renal tubular tumours exclusively in male rats. Although (+)-limonene is not carcinogenic in female rats or male and female mice given much higher dosages, the male rat-specific nephrocarcinogenicity of (+)-limonene may raise some concern regarding the safety of (+)-limonene for human consumption. A considerable body of scientific data has indicated that the renal toxicity of (+)-limonene results from the accumulation of a protein, alpha 2u-globulin, in male rat kidney proximal tubule lysosomes. This protein is synthesized exclusively by adult male rats. Other species, including humans, synthesize proteins that share significant homology with alpha 2u-globulin. However, none of these proteins, including the mouse equivalent of alpha 2u-globulin, can produce this toxicity, indicating a unique specificity for alpha 2u-globulin. With chronic exposure to (+)-limonene, the hyaline droplet nephropathy progresses and the kidney shows tubular cell necrosis, granular cast formation at the corticomedullary junction, and compensatory cell proliferation. Both (+)-limonene and cis-d-limonene-1,2-oxide (the major metabolite involved in this toxicity) are negative in vitro mutagenicity screens. Therefore, the toxicity-related renal cell proliferation is believed to be integrally involved in the carcinogenicity of (+)-limonene as persistent elevations in renal cell proliferation may increase fixation of spontaneously altered DNA or serve to promote spontaneously initiated cells. The scientific data demonstrates that the tumorigenic activity of (+)-limonene in male rats is not relevant to humans. The three major lines of evidence supporting the human safety of (+)-limonene are (1) the male rat specificity of the nephrotoxicity and carcinogenicity; (2) the pivotal role that alpha 2u-globulin plays in the toxicity, as evidenced by the complete lack of toxicity in other species despite the presence of structurally similar proteins; and (3) the lack of genotoxicity of both (+)-limonene and d-limonene-1,2-oxide, supporting the concept of a nongenotoxic mechanism, namely, sustained renal cell proliferation (PMID:2024047 ). |
---|
Structure | InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(+)-(4R)-Limonene | ChEBI | (+)-(R)-Limonene | ChEBI | (+)-4-Isopropenyl-1-methylcyclohexene | ChEBI | (+)-Limonene | ChEBI | (4R)-1-Methyl-4-isopropenylcyclohex-1-ene | ChEBI | (4R)-4-Isopropenyl-1-methylcyclohexene | ChEBI | (R)-(+)-Limonene | ChEBI | (R)-(+)-p-Mentha-1,8-diene | ChEBI | (R)-1-Methyl-4-(1-methylethenyl)cyclohexene | ChEBI | (R)-4-Isopropenyl-1-methyl-1-cyclohexene | ChEBI | (R)-p-Mentha-1,8-diene | ChEBI | 4BetaH-p-mentha-1,8-diene | ChEBI | D-(+)-Limonene | ChEBI | D-Limonen | ChEBI | AISA 5203-L (+)limonene | HMDB | Dipentene | HMDB | (-)-Limonene | HMDB | 1-Methyl-4-(1-methylethenyl)cyclohexene | HMDB | Limonene | HMDB | Limonene, (+-)-isomer | HMDB | (D)-Limonene | HMDB | 4-Mentha-1,8-diene | HMDB | Limonene, (R)-isomer | HMDB | (+)-Dipentene | HMDB | (+)-alpha-Limonene | HMDB | (+)-p-Mentha-1,8-diene | HMDB | (+)-Α-limonene | HMDB | (4R)-(+)-Limonene | HMDB | (4R)-1-Methyl-4-(1-methylethenyl)cyclohexene | HMDB | (4R)-Limonene | HMDB | (R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-1-ene | HMDB | (R)-Limonene | HMDB | 1-Methyl-4-prop-1-en-2-yl-cyclohexene | HMDB | (+)-(R)-4-Isopropenyl-1-methylcyclohexene | HMDB | D Limonene | HMDB | 4 Mentha 1,8 diene | HMDB | (R)-4-Isopropenyl-1-methylcyclohexene | HMDB | D-Limonene | ChEBI | d-Limonene | HMDB | (4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-1-ene | HMDB | R-Limonene | HMDB | p-Mentha-1,8-diene | PhytoBank | (±)-Dipentene | PhytoBank | (±)-Limonene | PhytoBank | (±)-alpha-Limonene | PhytoBank | (±)-α-Limonene | PhytoBank | 1,8-p-Menthadiene | PhytoBank | 1-Methyl-4-(prop-1-en-2-yl)cyclohex-1-ene | PhytoBank | 1-Methyl-4-isopropenyl-1-cyclohexene | PhytoBank | 1-Methyl-4-isopropenylcyclohexene | PhytoBank | 1-Methyl-p-isopropenyl-1-cyclohexene | PhytoBank | 4-Isopropenyl-1-methyl-1-cyclohexene | PhytoBank | 4-Isopropenyl-1-methylcyclohexene | PhytoBank | dl-Limonene | PhytoBank | Dipenten | PhytoBank | Limonen | PhytoBank | alpha-Limonene | PhytoBank | α-Limonene | PhytoBank |
|
---|
Chemical Formula | C10H16 |
---|
Average Molecular Weight | 136.234 |
---|
Monoisotopic Molecular Weight | 136.125200512 |
---|
IUPAC Name | (4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene |
---|
Traditional Name | α-limonene |
---|
CAS Registry Number | 5989-27-5 |
---|
SMILES | CC(=C)[C@@H]1CCC(C)=CC1 |
---|
InChI Identifier | InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1 |
---|
InChI Key | XMGQYMWWDOXHJM-JTQLQIEISA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as menthane monoterpenoids. These are monoterpenoids with a structure based on the o-, m-, or p-menthane backbone. P-menthane consists of the cyclohexane ring with a methyl group and a (2-methyl)-propyl group at the 1 and 4 ring position, respectively. The o- and m- menthanes are much rarer, and presumably arise by alkyl migration of p-menthanes. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Monoterpenoids |
---|
Direct Parent | Menthane monoterpenoids |
---|
Alternative Parents | |
---|
Substituents | - P-menthane monoterpenoid
- Monocyclic monoterpenoid
- Branched unsaturated hydrocarbon
- Cycloalkene
- Cyclic olefin
- Unsaturated aliphatic hydrocarbon
- Unsaturated hydrocarbon
- Olefin
- Hydrocarbon
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | -90 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 4.38 | GRIFFIN,S ET AL. (1999) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - (+)-Limonene EI-B (Non-derivatized) | splash10-0173-9100000000-239928f205c8242a700a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (+)-Limonene EI-B (Non-derivatized) | splash10-014l-9100000000-507f7afbc17b7c2556e2 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (+)-Limonene EI-B (Non-derivatized) | splash10-014l-9100000000-1a0c62c6971532ab6782 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (+)-Limonene EI-B (Non-derivatized) | splash10-0173-9100000000-239928f205c8242a700a | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (+)-Limonene EI-B (Non-derivatized) | splash10-014l-9100000000-507f7afbc17b7c2556e2 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (+)-Limonene EI-B (Non-derivatized) | splash10-014l-9100000000-1a0c62c6971532ab6782 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (+)-Limonene GC-EI-Q (Non-derivatized) | splash10-014l-9100000000-0b286d388287bcc487f2 | 2020-07-08 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Limonene GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9200000000-df40612bbf371089d7ac | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Limonene GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-014l-9100000000-fbf154446f93ee5019c0 | 2015-03-01 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - (+)-Limonene Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-6900000000-f7ee4bad43b6ccae0ccb | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (+)-Limonene Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-00ou-9000000000-51a52c25a98124e179e9 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (+)-Limonene Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0006-9000000000-9655665d3d36755028cc | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (+)-Limonene EI-B (HITACHI RMU-6M) , Positive-QTOF | splash10-0173-9100000000-239928f205c8242a700a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (+)-Limonene EI-B (HITACHI M-80B) , Positive-QTOF | splash10-014l-9100000000-bc8708fdb2d1955dce92 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (+)-Limonene EI-B (HITACHI M-80) , Positive-QTOF | splash10-014l-9100000000-1a0c62c6971532ab6782 | 2012-08-31 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 10V, Positive-QTOF | splash10-000i-2900000000-bce8f8616cfd3b16cac9 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 20V, Positive-QTOF | splash10-000i-9600000000-583a2621a826cedbca61 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 40V, Positive-QTOF | splash10-1000-9100000000-d78cd6fbdd7a13fe9dfa | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 10V, Negative-QTOF | splash10-000i-0900000000-2950ad058f77d7bc9f76 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 20V, Negative-QTOF | splash10-000i-0900000000-6f48f3b0b500d4f25ec9 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 40V, Negative-QTOF | splash10-014r-5900000000-1c30c00bfa4058f5e22b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 10V, Negative-QTOF | splash10-000i-0900000000-a013b4ae27f975ab5621 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 20V, Negative-QTOF | splash10-000i-0900000000-a013b4ae27f975ab5621 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 40V, Negative-QTOF | splash10-014i-8900000000-d835e92fba2c2a238797 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 10V, Positive-QTOF | splash10-001a-9400000000-fb09a1cdd4bc09480281 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 20V, Positive-QTOF | splash10-0564-9000000000-dc5effa7f00987fc8567 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Limonene 40V, Positive-QTOF | splash10-00mo-9000000000-40d99aa482e2ce5a66f1 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane (predicted from logP)
|
---|
Biospecimen Locations | - Blood
- Breath
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.19 (0.02 - 2.40) uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Children (1-13 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Newborn (0-30 days old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Breath | Detected but not Quantified | Not Quantified | Children (1-13 years old) | Not Specified | Asthma | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Nonalcoholic fatty liver disease (NAFLD) | | details | Feces | Detected but not Quantified | Not Quantified | Children (1-13 years old) | Both | Autism | | details | Feces | Detected but not Quantified | Not Quantified | Children (1-13 years old) | Both | Pervasive Developmental Disorder Not Otherwise Specified | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Campylobacter jejuni infection | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Clostridium difficile infection | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative Colitis | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Breast cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Asthma |
---|
- Gahleitner F, Guallar-Hoyas C, Beardsmore CS, Pandya HC, Thomas CP: Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath. Bioanalysis. 2013 Sep;5(18):2239-47. doi: 10.4155/bio.13.184. [PubMed:24053239 ]
| Ulcerative colitis |
---|
- Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21. [PubMed:17314143 ]
| Nonalcoholic fatty liver disease |
---|
- Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, Bailey J, Myers RP, Rioux KP: Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27. [PubMed:23454028 ]
| Autism |
---|
- De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013. [PubMed:24130822 ]
| Pervasive developmental disorder not otherwise specified |
---|
- De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013. [PubMed:24130822 ]
| Perillyl alcohol administration for cancer treatment |
---|
- Silva CL, Passos M, Camara JS: Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis. Talanta. 2012 Jan 30;89:360-8. doi: 10.1016/j.talanta.2011.12.041. Epub 2011 Dec 22. [PubMed:22284503 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB08921 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB006329 |
---|
KNApSAcK ID | C00010868 |
---|
Chemspider ID | 389747 |
---|
KEGG Compound ID | C06099 |
---|
BioCyc ID | CPD-4886 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Limonene |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 440917 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 15382 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | LIMNEN |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | v. Braun, Julius; Lemke, Georg. Preparation of pure d- and l-limonene. Berichte der Deutschen Chemischen Gesellschaft [Abteilung] B: Abhandlungen (1923), 56B 1562-3. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Bhatia KS, Singh J: Effect of linolenic acid/ethanol or limonene/ethanol and iontophoresis on the in vitro percutaneous absorption of LHRH and ultrastructure of human epidermis. Int J Pharm. 1999 Apr 15;180(2):235-50. [PubMed:10370194 ]
- Cal K, Janicki S, Sznitowska M: In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. Int J Pharm. 2001 Aug 14;224(1-2):81-8. [PubMed:11472817 ]
- Matura M, Goossens A, Bordalo O, Garcia-Bravo B, Magnusson K, Wrangsjo K, Karlberg AT: Oxidized citrus oil (R-limonene): a frequent skin sensitizer in Europe. J Am Acad Dermatol. 2002 Nov;47(5):709-14. [PubMed:12399762 ]
- Falk A, Gullstrand E, Lof A, Wigaeus-Hjelm E: Liquid/air partition coefficients of four terpenes. Br J Ind Med. 1990 Jan;47(1):62-4. [PubMed:2310709 ]
- Lim PF, Liu XY, Kang L, Ho PC, Chan YW, Chan SY: Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int J Pharm. 2006 Mar 27;311(1-2):157-64. Epub 2006 Jan 31. [PubMed:16451823 ]
- Yamane MA, Williams AC, Barry BW: Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol. 1995 Dec;47(12A):978-89. [PubMed:8932680 ]
- Cornwell PA, Barry BW, Stoddart CP, Bouwstra JA: Wide-angle X-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment. J Pharm Pharmacol. 1994 Dec;46(12):938-50. [PubMed:7536240 ]
- Flamm WG, Lehman-McKeeman LD: The human relevance of the renal tumor-inducing potential of d-limonene in male rats: implications for risk assessment. Regul Toxicol Pharmacol. 1991 Feb;13(1):70-86. [PubMed:2024047 ]
- Aggarwal BB, Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006 May 14;71(10):1397-421. Epub 2006 Feb 23. [PubMed:16563357 ]
- Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA: Cancer prevention by natural compounds. Drug Metab Pharmacokinet. 2004 Aug;19(4):245-63. [PubMed:15499193 ]
- DeWitt C, Bebarta V: Botanical solvents. Clin Occup Environ Med. 2004 Aug;4(3):445-54, v-vi. [PubMed:15325315 ]
|
---|